Clinical Trials Browser

Recruiting × Interviews as Topic × Head & Neck × Clear all

NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07225855 2026-05-11

Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers

Phase NA Recruiting

36 enrolled

Head & Neck

Localized Head and Neck Carcinoma

NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Phase NA Recruiting

118 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06985784 2025-11-10

Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers

Phase NA Recruiting

40 enrolled

Head & Neck

Head and Neck Carcinoma

NCT06236373 2024-12-09

Survivorship

Recruiting

45 enrolled

BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cell

Breast Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Colorectal Neoplasms, Neoplasms, Plasma Cell